These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8735640)

  • 1. Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo.
    Mathoôt RA; Soudijn W; Breimer DD; Ijzerman AP; Danhof M
    Br J Pharmacol; 1996 May; 118(2):369-77. PubMed ID: 8735640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial agonism of the nonselective adenosine receptor agonist 8-butylaminoadenosine at the A1 receptor in vivo.
    Mathot RA; Wenden EM; Soudijn W; Breimer DD; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1439-46. PubMed ID: 8968369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats.
    Mathôt RA; Cleton A; Soudijn W; IJzerman AP; Danhof M
    Br J Pharmacol; 1995 Feb; 114(4):761-8. PubMed ID: 7773536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline.
    Appel S; Mathôt RA; Langemeijer MW; IJzerman AP; Danhof M
    Br J Pharmacol; 1995 Aug; 115(7):1253-9. PubMed ID: 7582553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.
    Mathôt RA; Gubbens-Stibbe JM; Soudijn W; Jacobson KA; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 1995 Oct; 275(1):245-53. PubMed ID: 7562557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo.
    Mathôt RA; Van der Wenden EM; Soudijn W; IJzerman AP; Danhof M
    Br J Pharmacol; 1995 Oct; 116(3):1957-64. PubMed ID: 8640332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do adenosine receptors play a role in amitriptyline-induced cardiovascular toxicity in rats?
    Kalkan S; Aygoren O; Akgun A; Gidener S; Guven H; Tuncok Y
    J Toxicol Clin Toxicol; 2004; 42(7):945-54. PubMed ID: 15641640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A2A receptors facilitate 45Ca2+ uptake through class A calcium channels in rat hippocampal CA3 but not CA1 synaptosomes.
    Gonçalves ML; Cunha RA; Ribeiro JA
    Neurosci Lett; 1997 Nov; 238(1-2):73-7. PubMed ID: 9464658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity of action of 8-alkylamino analogues of N6-cyclopentyladenosine in vivo: haemodynamic versus anti-lipolytic responses in rats.
    van Schaick EA; Tukker HE; Roelen HC; IJzerman AP; Danhof M
    Br J Pharmacol; 1998 Jun; 124(3):607-18. PubMed ID: 9647488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-Alkylamino-substituted analogs of N6-cyclopentyladenosine are partial agonists for the cardiovascular adenosine A1 receptors in vivo.
    Van Schaick EA; Math-ot RA; Gubbens-Stibbe JM; Langemeijer MW; Roelen HC; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 1997 Nov; 283(2):800-8. PubMed ID: 9353401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic modelling of the anti-lipolytic and anti-ketotic effects of the adenosine A1-receptor agonist N6-(p-sulphophenyl)adenosine in rats.
    van Schaick EA; de Greef HJ; Langemeijer MW; Sheehan MJ; IJzerman AP; Danhof M
    Br J Pharmacol; 1997 Oct; 122(3):525-33. PubMed ID: 9351510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
    Schindler CW; Karcz-Kubicha M; Thorndike EB; Müller CE; Tella SR; Ferré S; Goldberg SR
    Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine receptor subtypes and vasodilatation in rat skeletal muscle during systemic hypoxia: a role for A1 receptors.
    Bryan PT; Marshall JM
    J Physiol; 1999 Jan; 514 ( Pt 1)(Pt 1):151-62. PubMed ID: 9831723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats.
    Wakeno M; Minamino T; Seguchi O; Okazaki H; Tsukamoto O; Okada K; Hirata A; Fujita M; Asanuma H; Kim J; Komamura K; Takashima S; Mochizuki N; Kitakaze M
    Circulation; 2006 Oct; 114(18):1923-32. PubMed ID: 17043167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial agonism of theophylline-7-riboside on adenosine receptors.
    IJzerman AP; van der Wenden EM; von Frijtag Drabbe Künzel JK; Mathôt RA; Danhof M; Borea PA; Varani K
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):638-45. PubMed ID: 7708121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of adenosine on blood pressure variability in sinoaortic denervated rats is mediated by adenosine A2a-Receptor.
    Shen FM; Su DF
    J Cardiovasc Pharmacol; 2000 Nov; 36(5):681-6. PubMed ID: 11065230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of R- and S-N6-phenylisopropyladenosine in conscious normotensive rats.
    Mathôt RA; Van den Aarsen BC; Soudijn W; Breimer DD; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 1995 Apr; 273(1):405-14. PubMed ID: 7714796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in rat heart.
    Norton GR; Woodiwiss AJ; McGinn RJ; Lorbar M; Chung ES; Honeyman TW; Fenton RA; Dobson JG; Meyer TE
    Am J Physiol; 1999 Feb; 276(2):H341-9. PubMed ID: 9950832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
    Karcz-Kubicha M; Antoniou K; Terasmaa A; Quarta D; Solinas M; Justinova Z; Pezzola A; Reggio R; Müller CE; Fuxe K; Goldberg SR; Popoli P; Ferré S
    Neuropsychopharmacology; 2003 Jul; 28(7):1281-91. PubMed ID: 12700682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes.
    Peakman MC; Hill SJ
    Br J Pharmacol; 1994 Jan; 111(1):191-8. PubMed ID: 8012696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.